Stock Quotes & Company News | Reuters.com
Edition:
United States

People: Ironwood Pharmaceuticals Inc (IRWD.O)

IRWD.O on Nasdaq

13.13USD
11:44am EDT
Change (% chg)

$0.16 (+1.23%)
Prev Close
$12.97
Open
$13.01
Day's High
$13.13
Day's Low
$12.85
Volume
207,738
Avg. Vol
1,560,184
52-wk High
$13.27
52-wk Low
$7.35

McCourt, Thomas 

Mr. Thomas A. McCourt is Senior Vice President - Marketing and Sales, Chief Commercial Officer of Ironwood Pharmaceuticals, Inc., since September 2009. Mr. McCourt led the U.S. brand team for denosumab at Amgen Inc. from April 2008 to August 2009. Prior to that, Mr. McCourt was with Novartis AG from 2001 to 2008, where he directed the launch and growth of Zelnorm for the treatment of patients with IBS-C and CIC and held a number of senior commercial roles, including vice president of strategic marketing and operations. Mr. McCourt was also part of the founding team at Astra Merck Inc., leading the development of the medical affairs and science liaison group and then serving as brand manager for Prilosec™ and NEXIUM®. Mr. McCourt has a degree in pharmacy from the University of Wisconsin.

Basic Compensation

Total Annual Compensation, USD 511,358
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 535,349
Fiscal Year Total, USD 1,046,710

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 40,000 468,000.00
Name Fiscal Year Total

Peter Hecht

2,252,130

Thomas Graney

2,308,020

Mark Currie

1,115,770

Thomas McCourt

1,046,710

Halley Gilbert

938,958

Andrew Dreyfus

--
As Of  30 Dec 2014